A role of functional T-type Ca2+ channel in hepatocellular carcinoma cell proliferation

Oncology Reports

Volumn 22, Issue 5, 2009, Pages 1229-1235

  Li, Yajuan ^a   Liu, Shuang ^b   Lu, Fengmin ^a   Zhang, Ting ^a   Chen, Hairu ^c   Wu, Songwei ^c   Zhuang, Hui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Hepatocellular carcinoma; Mibefradil; Proliferation; T type Ca2+ channel

Indexed keywords

CALCIUM CHANNEL T TYPE; MESSENGER RNA; MIBEFRADIL; MITOGEN ACTIVATED PROTEIN KINASE 3;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VOLTAGE CLAMP;

BLOTTING, WESTERN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; ELECTROPHYSIOLOGY; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MIBEFRADIL; MITOGEN-ACTIVATED PROTEIN KINASE 3; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 70449395480     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000559     Document Type: Article

References (28)

1. EI-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007.
2. Coleman WB: Mechanisms of human hepatocarcinogenesis. Curr Mol Med 3: 573-588, 2003.
3. Berridge MJ, Lipp P and Bootman MD: The versatility and universality of calcium signaling. Nat Rev Mol Cell Biol 1: 11-21, 2000.
4. McRory JE, Santi CM, Hamming KS, Mezeyova J, Sutton KG, Baillie DL, Stea A and Snutch TP: Molecular and functional characterization of a family of rat brain T-type calcium channels. J Biol Chem 276: 3999-4011, 2001.
5. Rodman DM, Reese K, Harral J, Fouty B, Wu S, West J, Hoedt-Miller M, Tada Y, Li KX, Cool C, Fagan K and Cribbs L: Low voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes. Circ Res 96: 864-872, 2005.
6. 2+ channels are involved in high glucose-induced rat neonatal cardiomyocyte proliferation. Pediatr Res 57: 550-556, 2005.
7. Panner A, Cribbs LL, Zainelli GM, Oriqitano TC, Singh S and Wurster RD: Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium 37: 105-119, 2005.
8. Mariot P, Vanoverberghe K, Lalevee N, Rossier MF and Prevarskaya N: Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 277: 10824-10833, 2002.
9. Hirooka K, Bertolesi GE, Kelly ME, Denovan-Wright EM, Sun X, Hamid J, Zamponi GW, Juhasz AE, Haynes LW and Barnes S: T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiation. J Neurophysiol 88: 196-205, 2002.
10. Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ and Calvet JP: Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279: 40419-40430, 2004.
11. 2+ channel expression in human esophageal carcinomas: a functional role in proliferation. Cell Calcium 43: 49-58, 2008.
12. 2+ channels suppresses human breast cancer cell proliferation. Cancer Lett 267: 116-124, 2008.
13. 2+ channels mediate vaso-occlusion of sickled erythrocytes in lung microcirculation. Circ Res 93: 346-353, 2003.
14. Martin RL, Lee JH, Cribbs LL, Perez-Reyes E and Hanck DA: Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 295: 302-308, 2000.
15. Asaga S, Ueda M, Jinno H, Kikuchi K, Itano O, Ikeda T and Kitajima M: Identification of a new breast cancer-related gene by restriction landmark genomic scanning. Anticancer Res 26: 35-42, 2006.
16. Massie C and Mills IG: The developing role of receptors and adaptors. Nat Rev Cancer 6: 403-409, 2006.
17. Kikuchi A and Yamamoto H: Tumor formation due to abnormalities in the beta-catenin-independent pathway of Wnt signaling. Cancer Sci 99: 202-208, 2008.
18. Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J and Lian Z: Genetic mechanisms of hepatocarcinogenesis. Oncogene 21: 2593-2604, 2002.
19. Hung WC, Chuang LY, Tsai JH and Chang CC: Effects of epidermal growth factor on growth control and signal transduction pathways in different human hepatoma cell lines. Biochem Mol Biol Int 30: 319-328, 1993.
20. Castillo J, Erroba E, Perugorría MJ, Santamaría M, Lee DC, Prieto J, Avila MA and Berasain C: Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res 66: 6129-6138, 2006.
21. Wiesenauer CA, Yip-Schneider MT, Wang Y and Schmidt CM: Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma. J Am Coll Surg 198: 410-421, 2004.
22. Fang JY and Richardson BC: The MAPK signaling pathways and colorectal cancer. Lancet Oncol 6: 322-327, 2005.
23. Torii S, Yamamoto T, Tsuchiya Y and Nishida E: ERK MAP kinase in G cell cycle progression and cancer. Cancer Sci 97: 697-702, 2006.
24. Kar S, Wang M, Yao W, Michejda CJ and Carr BI: PM-20, a novel inhibitor of Cdc25A, induces extracellular signal-regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo. Mol Cancer Ther 5: 1511-1519, 2006.
25. Goulet AC, Chigbrow M, Frisk P and Nelson MA: Selenomethionine induces sustained ERK phosphorylation leading to cell-cycle arrest in human colon cancer cells. Carcinogenesis 26: 109-117, 2005.
26. Osada S and Carr BI: Mechanism of novel vitamin K analog induced growth inhibition in human hepatoma cell line. J Hepatol 34: 676-682, 2001.
27. Nielsen NH, Arnerlov C, Cajander S and Landberg G: Cyclin E expression and proliferation in breast cancer. Anal Cell Pathol 17: 177-188, 1998.
28. Yamada S, Sumrejkanchanakij P, Amagasa T and Ikeda MA: Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway. Int J Cancer 111: 17-22, 2004.